TraceLink Inc., helping businesses securely supply every global market opportunity on-time and in-full with the TraceLink Business Cloud, announced today that Shabbir Dahod, TraceLink’s President and CEO, will be speaking at CBI – Pharmaceutical Technology’s Bio/Pharmaceutical Manufacturing Partnerships conference taking place July 24-25 in Philadelphia, PA. The conference provides a detailed look ways to improve outsourced manufacturing efficiency, increase quality oversight and mitigate production risk through strategic collaboration.

At the conference, Mr. Dahod will present the session “Utilizing Cloud and Business Collaboration Tools to Improve Performance and Reduce Risk in External Supply” on July 24th at 4:15 pm ET. This presentation will combine real-world case studies with recent research on supply network collaboration to explore:

• Global “pharmerging” market growth, outsourced manufacturing expansion, pharmaceutical serialization regulations and quality oversight requirements that are transforming outsourced production strategies;
• A high-performance, agile supply network architecture based on cloud computing, multi-enterprise collaboration workspaces and innovative network-wide data integration approaches; and,
• Benefits gained through better visibility, supply planning and manufacturing collaboration in improved order fulfillment, decreased time-to-market, inventory balance accuracy and reduced compliance risk.

“As Life Science companies seek to maximize revenue growth from global markets and cost savings from global outsourcing, they require a new strategic model for managing contract manufacturing and packaging,” said Shabbir Dahod, President and CEO of TraceLink. “Visibility across all external supply relationships, access to accurate and timely data at all points in the production lifecycle and cross-functional, cross-company collaboration is crucial in this environment. I am honored to join Pharmaceutical Technology magazine in discussing the supply chain capabilities required to ensure supply, capacity, quality and compliance in today’s global, virtual supply network.”

Mr. Dahod will join a noted group of experts on supply network collaboration, pharmaceutical quality, external supply management and regulatory compliance from Eli Lilly, BMS, Genentech, Covidien, Watson and the FDA.

To learn more about TraceLink’s solutions for creating an integrated and collaborative supply network, reducing risk through external quality management and oversight, improving supply planning with agile S&OP collaboration and protecting drug products from counterfeiting and theft such as the recent Genentech’s Avastin and Eli Lilly’s Prozac with safe and secure global distribution, visit www.tracelink.com.

About TraceLink

TraceLink helps companies securely supply every global market opportunity on-time and in-full through the TraceLink Business Cloud. The TraceLink Business Cloud is a cloud-based application platform that connects business transactions, partner networks and professional relationships across companies and functions. The result is improved visibility, predictability and performance across global supply, manufacturing and distribution operations. The TraceLink Business Cloud combines an “integrate-once, interoperate-with-everyone” transaction translation platform, user-managed business collaboration workspaces and cross-linked business process modules on a globally elastic cloud infrastructure to help companies realize their strategic goals in improving global supply network performance.

TraceLink is funded by FirstMark Capital, a venture capital firm managing more than $2 billion in capital commitments. For more information on TraceLink and our solutions, visit www.tracelink.com.